Deepull
Direct-from-blood multiplex PCR targeting 95% of sepsis-causing pathogens
$57M Series B+ ·
Led by Columbus Venture Partners · Source: startupintros.com
Total raised: $73.75M across 3 sourced rounds
All 3 rounds ↓Signals
Deepull | 299 days from website to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $57M | startupintros.com | ||
| Series B+ | $12.75M | globenewswire.com | ||
| Series A | $4M | startupintros.com |
Timeline
- Website created
Founders and team
JC
Jordi Carrera FounderRB
Rafel Bru Founder
Investors
AAliath Bioventures
AAlta Life Scienceslead investor
AAsabys Partners
AAXIS Participaciones Empresariales
CCentre for the Development of Industrial Technology (CDTI)lead investor
CColumbus Venture Partnerslead investor
KKurma Partnerslead investor
MMérieux Equity Partnerslead investor
PPanakes Partnerslead investor
UUI Investissement
WWe Venture Capital
Similar Health and bio companies
VVarmXSeries B+ · May 2023VVumedi$140M Series B+ · Nov 2026
NNeurosterix$105M Series B+ · Nov 2026
OOSMUNDA$14.99M Series B+ · Nov 2026
BBoston Medical Sciences$34.69M Series B+ · Nov 2026
AAraceli Biosciences$4.5M Seed · Nov 2026
Other companies backed by Columbus Venture Partners
OOna Therapeutics$86.6M Series B+ · Oct 2026
Columbus Venture Partners portfolio →
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/deepull (get a free API key).